Nobumasa Aoki

1.0k total citations
25 papers, 443 citations indexed

About

Nobumasa Aoki is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Nobumasa Aoki has authored 25 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 5 papers in Infectious Diseases and 5 papers in Oncology. Recurrent topics in Nobumasa Aoki's work include Pneumonia and Respiratory Infections (5 papers), Nosocomial Infections in ICU (4 papers) and Antifungal resistance and susceptibility (3 papers). Nobumasa Aoki is often cited by papers focused on Pneumonia and Respiratory Infections (5 papers), Nosocomial Infections in ICU (4 papers) and Antifungal resistance and susceptibility (3 papers). Nobumasa Aoki collaborates with scholars based in Japan and United States. Nobumasa Aoki's co-authors include Yoshinari Tanabe, Toshiaki Kikuchi, Hiroshi Moro, Toshiyuki Koya, Hiroki Tsukada, Takuro Sakagami, Satoshi Watanabe, Hiroshi Kagamu, Ichiei Narita and Takashi Hasegawa and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Nobumasa Aoki

23 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobumasa Aoki Japan 10 200 96 67 61 57 25 443
Kenji Umeki Japan 12 233 1.2× 134 1.4× 96 1.4× 32 0.5× 161 2.8× 42 542
Prayong Vachvanichsanong Thailand 17 161 0.8× 85 0.9× 80 1.2× 29 0.5× 139 2.4× 58 838
Sasima Tongsai Thailand 10 78 0.4× 78 0.8× 139 2.1× 61 1.0× 41 0.7× 39 390
P. Bonazzi Brazil 15 240 1.2× 69 0.7× 212 3.2× 129 2.1× 33 0.6× 26 606
Susan Knowles Ireland 11 117 0.6× 60 0.6× 37 0.6× 36 0.6× 42 0.7× 24 539
C. Ganesh Pai India 16 157 0.8× 71 0.7× 351 5.2× 93 1.5× 63 1.1× 56 686
Kentaro Akata Japan 15 207 1.0× 88 0.9× 92 1.4× 16 0.3× 150 2.6× 43 542
Julajak Limsrivilai Thailand 13 184 0.9× 142 1.5× 280 4.2× 24 0.4× 87 1.5× 57 647
Qijian Cheng China 12 277 1.4× 168 1.8× 60 0.9× 37 0.6× 161 2.8× 31 568
Francesco Amati Italy 15 248 1.2× 120 1.3× 55 0.8× 16 0.3× 424 7.4× 52 809

Countries citing papers authored by Nobumasa Aoki

Since Specialization
Citations

This map shows the geographic impact of Nobumasa Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobumasa Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobumasa Aoki more than expected).

Fields of papers citing papers by Nobumasa Aoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobumasa Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobumasa Aoki. The network helps show where Nobumasa Aoki may publish in the future.

Co-authorship network of co-authors of Nobumasa Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Nobumasa Aoki. A scholar is included among the top collaborators of Nobumasa Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobumasa Aoki. Nobumasa Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Moro, Hiroshi, et al.. (2024). Bacterial profiles detected in ventilator-associated pneumonia in Japan: A systematic review. Respiratory Investigation. 62(3). 365–368. 4 indexed citations
3.
Moro, Hiroshi, Kei Nagano, Satoshi Shibata, et al.. (2023). Dynamics of iron metabolism in patients with bloodstream infections: a time-course clinical study. Scientific Reports. 13(1). 19143–19143. 3 indexed citations
4.
Ichikawa, Kosuke, Satoshi Watanabe, Satoru Miura, et al.. (2022). Prognostic significance of procalcitonin in small cell lung cancer. Translational Lung Cancer Research. 11(1). 43–52. 11 indexed citations
5.
Aoki, Nobumasa, Satoshi Shibata, Yasuyoshi Ohshima, et al.. (2022). Factors associated with cytomegalovirus antigenemia in patients with rheumatic disease: A retrospective study. Journal of Infection and Chemotherapy. 28(11). 1471–1477. 1 indexed citations
6.
Hayashi, Masachika, Satoshi Hokari, Nobumasa Aoki, et al.. (2021). A case of bronchiolitis obliterans after living-donor renal transplantation. Respiratory Investigation. 59(3). 367–371. 2 indexed citations
7.
Nagano, Kei, Hiroshi Moro, Satoshi Shibata, et al.. (2021). Efficacy of the new β-D-glucan measurement kit for diagnosing invasive fungal infections, as compared with that of four conventional kits. PLoS ONE. 16(8). e0255172–e0255172. 8 indexed citations
8.
Nagano, Kei, Satoshi Kawasaki, Hiroshi Moro, et al.. (2021). An outbreak of serotype 19A pneumococcal pneumonia in a relief facility in Japan. Infection Control and Hospital Epidemiology. 43(12). 1934–1936. 1 indexed citations
9.
Ueno, Hiroshi, Masachika Hayashi, Kosuke Ichikawa, et al.. (2020). Disseminated Varicella-zoster Virus Infection Causing Fatal Pneumonia in an Immunocompromised Patient with Chronic Interstitial Pneumonia. Internal Medicine. 60(7). 1077–1082. 8 indexed citations
10.
Shoji, Satoshi, Michihiro Hosojima, Hideyuki Kabasawa, et al.. (2019). Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study. BMC Cancer. 19(1). 1170–1170. 7 indexed citations
11.
Moro, Hiroshi, Nobumasa Aoki, Yasuyoshi Ohshima, et al.. (2019). Multiplex cytokine analysis in Mycobacterium avium complex lung disease: relationship between CXCL10 and poor prognostic factors. BMC Infectious Diseases. 19(1). 263–263. 5 indexed citations
12.
Sato, Miyuki, Satoshi Watanabe, Hiroshi Tanaka, et al.. (2019). Retrospective analysis of antitumor effects and biomarkers for nivolumab in NSCLC patients with EGFR mutations. PLoS ONE. 14(4). e0215292–e0215292. 10 indexed citations
13.
Moro, Hiroshi, Nobumasa Aoki, Yasuyoshi Ohshima, et al.. (2018). Increased presepsin levels are associated with the severity of fungal bloodstream infections. PLoS ONE. 13(10). e0206089–e0206089. 23 indexed citations
14.
Sato, Miyuki, Satoshi Watanabe, Nobumasa Aoki, et al.. (2018). [A Case of Drug-Induced Organizing Pneumonia Caused by Dasatinib].. PubMed. 45(5). 851–854. 5 indexed citations
15.
Noguchi, Shingo, Kazuhiro Yatera, Toshinori Kawanami, et al.. (2017). Pneumonia Severity Assessment Tools for Predicting Mortality in Patients with Healthcare-Associated Pneumonia: A Systematic Review and Meta-Analysis. Respiration. 93(6). 441–450. 10 indexed citations
16.
Tsukada, Hiroki, Satoshi Shibata, Satoshi Hokari, et al.. (2017). A-DROP system for prognostication of NHCAP inpatients. Journal of Infection and Chemotherapy. 23(8). 523–530. 18 indexed citations
17.
Moro, Hiroshi, Nobumasa Aoki, Masachika Hayashi, et al.. (2017). The Effect of Intravenous Gamma-globulin Reagents on the Measurement Results of (1→3)-β-D-glucan. Kansenshogaku zasshi. 91(1). 1–6. 2 indexed citations
18.
Komiya, Kosaku, Bruce K. Rubin, Jun‐ichi Kadota, et al.. (2016). Prognostic implications of aspiration pneumonia in patients with community acquired pneumonia: A systematic review with meta-analysis. Scientific Reports. 6(1). 38097–38097. 62 indexed citations
19.
Hasegawa, Takashi, Kazuo Suzuki, Yoshinari Tanabe, et al.. (2014). Analysis of the Influenza A (H1N1) 2009 Pandemic Infection in Japanese Asthmatic Patients: Using a Questionnaire-Based Survey. Allergology International. 63(1). 67–74. 3 indexed citations
20.
Shima, Kenjiro, Takuro Sakagami, Yoshinari Tanabe, et al.. (2013). Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients. Journal of Infection and Chemotherapy. 20(1). 52–56. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026